FEATURED ARTICLE

Characterization of 3 Novel Tau Radiopharmaceuticals, ¹¹C-RO-963, ¹¹C-RO-643, and ¹⁸F-RO-948, in Healthy Controls and in Alzheimer Subjects. Dean Wong et al. See page 1869.

One-stop-shop stage prediction: is ⁶⁸Ga-PSMA-11 PET/MRI preoperative stage prediction in high-risk prostate cancer equal to conventional nomograms—but with added anatomic information? Mark Thalgott et al. See page 1850.

Advancing Aβ PET imaging: preclinical studies with a novel antibody-based PET radioligand can monitor both brain Aβ disease progression and treatment effects achieved by inhibition of Aβ production. Silvio Meier et al. See page 1885.